Chronic Inflammatory Demyelinating Polyneuropathy: Current Therapies and Emerging Horizons
In this MEDtalk, Anders Svenningsson, MD, PhD, Professor at the Karolinska Institute in Sweden, discusses current treatment strategies for chronic inflammatory demyelinating polyneuropathy (CIDP), with considerations for both younger and older patient populations. He also shares his perspective on emerging therapies and offers insights into the future direction of CIDP management.
Få tillgång
Om du är läkare, sjuksköterska eller annan vårdpersonal kan du komma åt hela artikeln genom att skapa en profil på BestPractice Nordic.
- Få tillgång
- Om du redan har en profil: Logga in
